In my first post on this blog, I set myself 3 PhD-related goals for 2017. One of those goals was to read more widely, and more frequently, and I decided that doing the #365papers challenge would be a good way to do that.
Here’s my March update. I found this month reallt difficult to be honest, I was super busy with other things at work and didn’t feel like reading when I had a to do list longer than my arm. I missed a few days in a row and towards the end of the month when I had 10 papers to catch up on, I was making excuses and looking for ways to wriggle out of the challenge. I didn’t though – hoorah! I made time to read and now I’m all caught up.
- Promoting recruitment using information management efficiently (PRIME): study protocol for a stepped-wedge cluster randomised controlled trial within the Restart or Stop Antithrombotics Randomised Trial (RESTART)
- A little more conversation please? Qualitative study of researchers’ and patients’ interview account of training for patient and public involvement in clinical trials
- Are there fundamental deficiencies in megatrial methodology?
- Managing clinical trials
- From protocol to published report: a study of consistency in the reporting of academic drug trials
- Understanding controlled trials: why are randomised controlled trials so important?
- Understanding controlled trials: baseline imbalance in randomised controlled trials
- Understanding controlled trials: randomising groups of patients
- Using marketing theory to inform strategies for recruitment: a recruitment optimisation model and the txt2stop experience
- The natural history of conducting and reporting clinical trials: interviews with trialists
- Understanding controlled trials: what is a patient preference trial?
- Strategies for increasing recruitment to randomised controlled trials: systematic review
- Why clinical trial outcomes fail to translate into benefits for patients
- Blog – How marketing is undermining clinical trials
- Marketing trials, marketing tricks – how to spot them and how to stop them
- The changing face of clinical trials: pragmatic trials
- Equipoise across the patient population: optimising recruitment to a randomised controlled trial
- Why prudence is needed when interpreting articles reporting clinical trial results in mental health
- The possibility of critical realist randomised controlled trials
- The association of funding source on effect size in randomised controlled trials: 2013-2016 – a cross-sectional survey and meta-analysis
- Improving the recruitment activity of clinicians in randomised controlled trials: a systematic review
- Registry-based pragmatic trials in heart failure: current experience and future directions
- Barriers to recruitment in pediatric obesity trials: comparing opt-in an dopt-out recruitment approaches
- Sharing raw data from clinical trials: what progress since we first asked “Whose data set is it anyway?”
- Pharmafile Opinion – Are we prepared for the ‘real world’?
- Experience with direct-to-patient recruitment for enrollment into a clinical trial in a rare disease: a web-based study
- Financial Times article – Small patient groups hinder progress of clinical trials
- Fast Company, 3 Minute Read – This compay is helping patients get paid for their influence
- Recruitment of minority adolescents and young adults into randomised clinical trials: testing the design of the technology enhanced community health nursing (Tech-N) pelvic inflammatory disease trial
- When clinical trials compete: prioritizing study recruitment
- The continuing unethical conduct of underpowered clinical trials
If you have any recommended reads that are related to clinical trials/methodology/health services research and that kind of thing, I’d welcome them!